[HTML][HTML] Tumor microenvironment complexity and therapeutic implications at a glance
R Baghban, L Roshangar… - Cell Communication and …, 2020 - Springer
The dynamic interactions of cancer cells with their microenvironment consisting of stromal
cells (cellular part) and extracellular matrix (ECM) components (non-cellular) is essential to …
cells (cellular part) and extracellular matrix (ECM) components (non-cellular) is essential to …
[HTML][HTML] Non-invasive biomarkers for early detection of breast cancer
Simple Summary Early diagnosis of breast cancer greatly increases the chance of cure and
survival from the disease. The mammogram is widely used for early detection of breast …
survival from the disease. The mammogram is widely used for early detection of breast …
[HTML][HTML] Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: current status and perspectives
Oral cancer is the sixth most common cancer type in the world, and 90% of it is represented
by oral squamous cell carcinoma (OSCC). Despite progress in preventive and therapeutic …
by oral squamous cell carcinoma (OSCC). Despite progress in preventive and therapeutic …
[HTML][HTML] Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies
The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …
[HTML][HTML] Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
S Wang, K Zhang, S Tan, J Xin, Q Yuan, H Xu, X Xu… - Molecular cancer, 2021 - Springer
Cancer is a leading cause of death worldwide, particularly because of its high mortality rate
in patients who are diagnosed at late stages. Conventional biomarkers originating from …
in patients who are diagnosed at late stages. Conventional biomarkers originating from …
[HTML][HTML] Peripheral blood-based biomarkers for immune checkpoint inhibitors
As cancer immunotherapy using immune checkpoint inhibitors (ICIs) is rapidly evolving in
clinical practice, it is necessary to identify biomarkers that will allow the selection of cancer …
clinical practice, it is necessary to identify biomarkers that will allow the selection of cancer …
Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer
Background Metastatic castration-resistant prostate cancer (mCRPC) is the lethal form of the
disease. Several recent studies have identified genomic alterations in mCRPC, but the …
disease. Several recent studies have identified genomic alterations in mCRPC, but the …
[HTML][HTML] Liquid biopsy in oral cancer
F Lousada-Fernandez, O Rapado-Gonzalez… - International journal of …, 2018 - mdpi.com
Oral cancer is one of the most prevalent forms of cancer worldwide. Carcinogenesis is a
complex process, in which heterogeneity plays an important role in the development and …
complex process, in which heterogeneity plays an important role in the development and …
[HTML][HTML] Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
J Li, X Han, X Yu, Z Xu, G Yang, B Liu, P Xiu - Journal of Experimental & …, 2018 - Springer
Hepatocellular carcinoma (HCC) is a highly malignant disease with a poor prognosis and
high mortality due to a low early diagnosis rate, resistance to systemic treatments and …
high mortality due to a low early diagnosis rate, resistance to systemic treatments and …
[HTML][HTML] Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA
MA Kerachian, M Azghandi, S Mozaffari-Jovin… - Clinical …, 2021 - Springer
Methylation analysis of circulating cell-free DNA (cirDNA), as a liquid biopsy, has a
significant potential to advance the detection, prognosis, and treatment of cancer, as well as …
significant potential to advance the detection, prognosis, and treatment of cancer, as well as …